Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients
- 31 May 2002
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 126 (1-2), 205-212
- https://doi.org/10.1016/s0165-5728(02)00064-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Increased numbers of CCR5+ interferon-?- and tumor necrosis factor-?-secreting T lymphocytes in multiple sclerosis patientsAnnals of Neurology, 2000
- CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosisJournal of Neuroimmunology, 2000
- CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.JCI Insight, 1998
- Management of Multiple SclerosisNew England Journal of Medicine, 1997
- The Role of CD40 Ligand in Costimulation and T‐Cell ActivationImmunological Reviews, 1996
- Activation of Dual T Cell Signaling Pathways by the Chemokine RANTESScience, 1995
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993
- Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.The Journal of Experimental Medicine, 1993
- Macrophage inflammatory protein-1 alpha activates basophils and mast cells.The Journal of Experimental Medicine, 1992
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991